Literature DB >> 22472398

Poor prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma in the modern era.

Eiji Tsujita1, Yo-Ichi Yamashita, Kazuki Takeishi, Ayumi Matsuyama, Shin-Ichi Tsutsui, Hiroyuki Matsuda, Takeo Toshima, Akinobu Taketomi, Ken Shirabe, Teruyoshi Ishida, Yoshihiko Maehara.   

Abstract

The purpose of this study was to determine the poor prognostic factors after repeat hepatectomy (Hx) in patients with recurrent hepatocellular carcinoma (HCC). Overall survival rates and clinicopathological variables in 112 patients with repeat Hx from 1992 to 2010 were compared with those in 531 patients who underwent a primary Hx. To clarify the poor prognosis factors after repeat Hx, survival data among 112 patients were univariately and multivariately analyzed. Overall survival after repeat Hx was similar for that of the patients who underwent a primary Hx. The mean age of repeat Hx group was significantly higher, and a well-preserved liver function was recognized than the primary Hx group. Multivariate analysis revealed that: 1) indocyanine green retention rate at 15 minutes; 2) disease-free interval; 3) tumor size; 4) portal vein invasion at primary Hx; 5) gender; and 6) estimated blood loss to be an independent and significant poor prognostic factors. The overall 3-year postrecurrence overall survival rates were 100, 91.3, 59.6, and 0 per cent at risk number (R) R0, R1/2, R3, R4, respectively (P < 0.05). Repeat Hx provided a good compatible prognosis with primary Hx. In our findings, five risk factors to predict poor outcomes after repeat Hx were useful. Patients with recurrent HCC do not have universally poor outcomes, and our simple scoring system using five poor prognostic factors could serve to advise the prognosis and the potential benefit for patient selection about repeat Hx.

Entities:  

Mesh:

Year:  2012        PMID: 22472398

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  6 in total

1.  Hepatocellular carcinoma: clinical study of long-term survival and choice of treatment modalities.

Authors:  Ke-Tong Wu; Cun-Chuan Wang; Li-Gong Lu; Wei-Dong Zhang; Fu-Jun Zhang; Feng Shi; Chuan-Xing Li
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

Review 2.  Hepatectomy for hepatocellular carcinoma in the era of liver transplantation.

Authors:  Wen-Ping Lu; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

3.  Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy.

Authors:  Kazuki Takeishi; Hirofumi Kawanaka; Shinji Itoh; Norifumi Harimoto; Toru Ikegami; Tomoharu Yoshizumi; Ken Shirabe; Yoshihiko Maehara
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

Review 4.  Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma.

Authors:  Yoji Kishi; Kazuaki Shimada; Satoshi Nara; Minoru Esaki; Tomoo Kosuge
Journal:  World J Hepatol       Date:  2014-12-27

5.  A Novel Nomogram to Predict Prolonged Survival After Hepatectomy in Repeat Recurrent Hepatocellular Carcinoma.

Authors:  Qiongxuan Fang; Ruifeng Yang; Dongbo Chen; Ran Fei; Pu Chen; Kangjian Deng; Jie Gao; Weijia Liao; Hongsong Chen
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

6.  Ultrasound-guided radiofrequency ablation enhances natural killer-mediated antitumor immunity against liver cancer.

Authors:  Zelai Mo; Hailan Lu; Shaowei Mo; Xiangmin Fu; Shunwu Chang; Jie Yue
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.